The Analyst

Fluorescent biosensors using aptamers and CRISPR-Cas12a to detect markers in blood serum

Updated

Abstract

The CRISPR-Cas12a system enables sensitive nucleic acid detection due to its programmability, trans-cleavage activity, and biocompatibility.

  • Aptamers are recognized as effective recognition elements due to their high specificity and flexibility in design.
  • Integrating Cas12a with aptamers allows for the conversion of target-binding signals into nucleic acid recognition signals.
  • This combination facilitates signal amplification for the detection of non-nucleic acid targets.
  • Recent advances include the development of Cas12a-aptamer-based fluorescent biosensors aimed at serum biomarker detection.
  • The review discusses advantages, limitations, current challenges, and future prospects of the Cas12a system.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free